Explain this page
Arphra AIPlain-English read on Williams-Sonoma, Inc.’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|
| Headline | ||||||||
| Market cap | — | — | — | — | — | — | — | — |
| Enterprise value | — | — | — | — | — | — | — | — |
| Multiples | ||||||||
| P / E | — | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — |
| Yields | ||||||||
| Earnings yield | — | — | — | — | — | — | — | — |
| Free cash flow yield | — | — | — | — | — | — | — | — |
| Dividend yield | — | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross margin | +44.05% | +42.40% | +42.62% | +46.45% | +46.15% | +44.00% | +45.30% | +45.20% |
| Operating margin | +17.62% | +17.27% | +16.05% | +18.55% | +18.13% | +17.55% | +17.30% | +17.98% |
| EBITDA margin | +20.00% | +19.74% | +19.05% | +21.53% | +21.10% | +20.72% | +20.00% | +20.09% |
| EBIT margin | +17.62% | +17.27% | +16.05% | +18.55% | +18.13% | +17.85% | +17.39% | +18.03% |
| Pre-tax margin | +17.60% | +17.30% | +16.43% | +19.27% | +18.61% | +18.41% | +17.62% | +18.02% |
| Net margin | +13.66% | +13.00% | +12.25% | +14.59% | +13.94% | +13.20% | +13.38% | +13.65% |
| Cost structure | ||||||||
| Cost of revenue / sales | +55.95% | +57.60% | +57.38% | +53.55% | +53.85% | +55.18% | +55.83% | +56.45% |
| R&D intensity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| SG&A intensity | +26.42% | +25.12% | +26.57% | +27.91% | +28.02% | +27.63% | +26.68% | +27.02% |
| Effective tax rate | +22.39% | +24.84% | +25.41% | +24.26% | +25.07% | +24.13% | +25.78% | +25.50% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|
| Returns | ||||||||
| Return on equity (ROE) | +67.68% | +66.31% | +44.63% | +52.52% | +52.26% | +48.55% | +50.20% | +51.27% |
| Return on assets (ROA) | +24.35% | +24.19% | +18.01% | +21.22% | +20.11% | +19.22% | +19.26% | +19.35% |
| Return on capital (ROC) | +49.28% | +47.65% | +35.36% | +40.98% | +40.00% | +38.93% | +38.54% | +40.33% |
| Return on invested capital (ROIC) | +38.20% | +35.87% | +26.99% | +32.24% | +30.75% | +29.28% | +29.80% | +30.62% |
| Asset turnover | +178.27% | +186.03% | +146.97% | +145.46% | +144.25% | +145.64% | +143.97% | +141.70% |
| DuPont · ROE decomposition | ||||||||
| Net margin | +13.66% | +13.00% | +12.25% | +14.59% | +13.94% | +13.20% | +13.38% | +13.65% |
| Asset turnover (× revenue / assets) | +178.27% | +186.03% | +146.97% | +145.46% | +144.25% | +145.64% | +143.97% | +141.70% |
| Equity multiplier (× assets / equity) | +277.95% | +274.13% | +247.83% | +247.46% | +259.87% | +252.62% | +260.65% | +265.04% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||
| Asset turnover | 1.78 | 1.86 | 1.47 | 1.45 | 1.44 | 1.46 | 1.44 | 1.42 |
| Fixed-asset turnover | 4.02 | 3.69 | 3.46 | 3.49 | 3.30 | — | — | — |
| Inventory turnover | 3.70 | 3.43 | 3.57 | 3.10 | 2.87 | — | — | — |
| Receivables turnover | 62.62 | 74.98 | 63.06 | 65.53 | 61.56 | — | — | — |
| Payables turnover | 7.53 | 9.83 | 7.32 | 6.40 | 6.59 | — | — | — |
| Days outstanding | ||||||||
| Days sales outstanding (DSO) | 5.83 | 4.87 | 5.79 | 5.57 | 5.93 | — | — | — |
| Days inventory outstanding (DIO) | 98.60 | 106.37 | 102.30 | 117.78 | 127.01 | — | — | — |
| Days payables outstanding (DPO) | 48.45 | 37.13 | 49.89 | 57.07 | 55.39 | — | — | — |
| Cash conversion cycle | 55.97 | 74.10 | 58.19 | 66.28 | 77.55 | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|
| Operating CF / Net income | 1.22 | 0.93 | 1.77 | 1.21 | 1.21 | 1.45 | 1.41 | 1.33 |
| FCF / Net income | 1.02 | 0.62 | 1.57 | 1.01 | 0.97 | 1.17 | 1.17 | 1.13 |
| FCF margin | +13.88% | +8.05% | +19.25% | +14.77% | +13.52% | +15.46% | +15.63% | +15.49% |
| OCF margin | +16.63% | +12.14% | +21.68% | +17.64% | +16.84% | +19.09% | +18.80% | +18.20% |
| CapEx / Revenue | +2.75% | +4.08% | +2.43% | +2.87% | +3.32% | +2.89% | +2.92% | +2.86% |
| CapEx / D&A | 1.16 | 1.65 | 0.81 | 0.96 | 1.12 | — | — | — |
| Stock-based comp / Revenue | +1.15% | +1.04% | +1.09% | +1.28% | +1.36% | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|
| EPS · diluted | 7.38 | 8.16 | 7.28 | 8.79 | 8.84 | 9.36 | 10.22 | 11.36 |
| EPS · basic | 7.58 | 8.29 | 7.35 | 8.91 | 8.96 | 9.49 | 10.25 | 11.35 |
| Book value / share | 10.90 | 12.31 | 16.30 | 16.73 | 16.91 | 17.83 | 18.54 | 19.53 |
| Tangible BV / share | 10.34 | 11.75 | 15.71 | 16.13 | 16.28 | 17.83 | 18.54 | 19.53 |
| Sales / share | 54.00 | 62.77 | 59.37 | 60.23 | 63.39 | 65.61 | 69.57 | 73.36 |
| Operating CF / share | 8.98 | 7.62 | 12.87 | 10.62 | 10.68 | 12.53 | 13.08 | 13.35 |
| Free cash flow / share | 7.50 | 5.06 | 11.43 | 8.89 | 8.57 | 10.14 | 10.87 | 11.36 |
| Dividends / share | 1.23 | 1.57 | 1.78 | 2.19 | 2.57 | 2.32 | 2.43 | 2.58 |
| Payout ratio | +16.65% | +19.27% | +24.48% | +24.89% | +29.08% | +26.80% | +26.09% | +25.75% |
| Retention ratio | +83.35% | +80.73% | +75.52% | +75.11% | +70.92% | +73.20% | +73.91% | +74.25% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | 2027E | 2028E | 2029E | 7y CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Top-line | |||||||||
| Revenue · YoY | — | +5.20% | -10.65% | -0.50% | +1.24% | +4.52% | +4.81% | +5.46% | +1.29% |
| Gross profit · YoY | — | +1.26% | -10.17% | +8.44% | +0.58% | -0.34% | +7.89% | +5.23% | +1.66% |
| Profit | |||||||||
| Operating income · YoY | — | +3.12% | -16.97% | +14.95% | -1.01% | +1.14% | +3.32% | +9.63% | +1.58% |
| EBITDA · YoY | — | +3.84% | -13.77% | +12.41% | -0.77% | +2.66% | +1.16% | +5.95% | +1.36% |
| Net income · YoY | — | +0.14% | -15.79% | +18.48% | -3.27% | -1.06% | +6.25% | +7.63% | +1.28% |
| Operating | |||||||||
| EBIT · YoY | — | +3.12% | -16.97% | +14.95% | -1.01% | +2.88% | +2.13% | +9.32% | +1.62% |
| R&D · YoY | — | — | — | — | — | — | — | — | — |
| Per-share | |||||||||
| EPS · diluted · YoY | — | +10.65% | -10.80% | +20.74% | +0.57% | +5.93% | +9.12% | +11.14% | +6.36% |
| EPS · basic · YoY | — | +9.34% | -11.35% | +21.22% | +0.56% | +5.92% | +7.97% | +10.76% | +5.93% |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|
| Leverage | ||||||||
| Total debt | $1.28B | $1.44B | $1.39B | $1.35B | $1.46B | $1.46B | $1.56B | $1.62B |
| Net debt | $433.91M | $1.08B | $128.61M | $134.34M | $437.1M | $227.42M | $290.88M | $282.39M |
| Net debt / EBITDA | 0.26 | 0.63 | 0.09 | 0.08 | 0.27 | 0.13 | 0.17 | 0.16 |
| Debt / equity | 0.77 | 0.85 | 0.65 | 0.63 | 0.70 | 0.66 | 0.68 | 0.67 |
| Debt / assets | +27.76% | +30.96% | +26.37% | +25.41% | +26.92% | +26.07% | +26.26% | +25.45% |
| Equity / assets | +35.98% | +36.48% | +40.35% | +40.41% | +38.48% | +39.58% | +38.37% | +37.73% |
| Coverage | ||||||||
| EBITDA / interest expense | 884.29 | — | — | — | — | — | — | — |
| Operating income / interest | 779.15 | — | — | — | — | — | — | — |
| Interest expense | $1.87M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Liquidity | ||||||||
| Current ratio | 1.31 | 1.24 | 1.45 | 1.44 | 1.39 | — | — | — |
| Quick ratio | 0.55 | 0.30 | 0.74 | 0.70 | 0.59 | — | — | — |
| Cash ratio | 0.48 | 0.22 | 0.67 | 0.63 | 0.52 | — | — | — |
| Working capital | $552.21M | $399.63M | $839.48M | $842.64M | $759.06M | — | — | — |
| Working capital / revenue | +6.70% | +4.61% | +10.83% | +10.93% | +9.72% | — | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).